emerge semaglutide GLP-1 medications are dominating the conversation right now, but most of that conversation has focused on just one thing: weight loss. A different clinical question is starting to emerge…Could GLP-1 therapies offer Semaglutide for Weight Loss |
Description
Neuland announces a $30mn investment to expand its global Peptide production capabilities

We spoke with an Ob...

For anti-obesity GLP-1s, Medicares policy of not covering AOMs means that utilization skews heavily Commercial

Mechanisms for liraglutide-induced weight loss are poorly understood

Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease
In a randomized phase 3a study published in Diabetes Care, those taking oral semaglutide monotherapy experienced superior and clinically significant improvements in A1c and weight loss compared to those taking Continue reading Oral GLP-1 RA lowers Weight and A1c
